Oclacitinib malate
Olacitinib Malaste HmoovYog tus tshiab me - molecule khoom uas tau siv dav hauv cov tshuaj kho tsiaj nyob rau xyoo tas los no. Nws zwm rau chav kawm ntawm Janus Kinase (JAK) interibitors. Jaks yog intracellular tyrosine kinases uas feem ntau koom nrog hauv cytokine signaling. Thaum muaj kev fab tshuaj tiv thaiv tshwm sim, xws li IL {}}}} Los ntawm inhibiting qhov kev ua ntawm cov kab ke no, o -clacitinib block ntawm kev teeb liab ntawm cov khaus khaus khaus, tau ua kom khaus sai sai. Nws yog tsim raws li kev tsim kho ntsev, feem ntau los txhim kho cov tshuaj ruaj khov thiab qhov ncauj nqus.
Nrog rau cov lus tsis ntev los no ntawm Jak inhibitors (xws li Toffacitinib thiab Baricitinib) nyob rau hauv tib neeg cov tshuaj, kev ua tiav ntawm cov kws kho tsiaj teb, ua tiav ob qho tib si sib xws thiab sib txawv hauv cov tsiaj lag luam hauv chaw muag tshuaj thoob plaws hom. Piv nrog tsoos anti {-}} ineting qhia sai dua, thiab muaj kev sib raug zoo, thiab kev sib raug zoo ua kom pom tau sai dua, thiab kev sib raug zoo ntawm cov kab mob ntawm cov dev. Nws tau maj mam dhau los ua ib qho kev xaiv tseem ceeb rau kev kho cov kab mob hauv cov kwj dej. Muab nws cov txiaj ntsig, cov neeg muab khoom rau PF 03394197 hauv kev ua lag luam nce ntxiv. Xi'an Sonwu muab siab - Zoo PF 03394197 hmoov. Yog xav paub ntxiv txog cov khoom no, thov mus ntsib nrog Xi'an Sonwu.

Daim Ntawv Pov Thawj Kev Ntsuam Xyuas
|
Xeem ntawv |
Cov lus qhia |
Qho kawg |
|
Daim qhia npe
|
(1) los ntawm IR, kom phim nrog cov qauv ua haujlwm |
Ua raws |
|
(2) hplc |
Ua raws |
|
|
Impurities a |
Tsawg dua los yog sib npaug rau 0.1% |
Tsis pom |
|
Lwm Cov Zos
|
Ib tug impurity tsawg dua los yog sib npaug rau 0.1% |
<0.1% |
|
Tag nrho cov impurities tsawg dua los yog sib npaug rau 0.4% |
Ua raws |
|
|
Residual cov kuab tshuaj |
Acetidi tsawg dua los yog sib npaug rau 0.5% |
Ua raws |
|
Dichhlorometha tsawg dua lossis sib npaug rau 0.06% |
Ua raws |
|
|
Methan tsawg dua los yog sib npaug rau 0.3% |
Ua raws |
|
|
Aceton tsawg dua los yog sib npaug rau 0.5% |
Ua raws |
|
|
Acetonitri tsawg dua lossis sib npaug rau 0.041% |
Tsis pom |
|
|
Ethanol tsawg dua lossis sib npaug rau 0.5% |
Ua raws |
|
|
N, n {- dimethylformamide n tsawg dua lossis sib npaug rau 0.088% |
Ua raws |
|
|
Ywg dej |
Tsawg dua los yog sib npaug rau 0.1% |
Ua raws |
|
Lam xav |
98.0% -102.0% (ntawm anhydrous hauv paus) |
99.4% |
Qhov twg yuav pf 03394197
Xi'an Songwu Biotech Co. Ltd. muaj ntau tshaj kaum xyoo ntawm kev paub kev lag luam, tshwj xeeb hauv kev tsim khoom thiab muag khoom ntawm raw khoom. Xi'an Sonwu tau tsim muaj zog thiab txhim khu kev qha nrog cov tebchaws nyob hauv Asmeskas, Asia, Europe, Europe thiab Oceania. Xi'an Sonwu muab cov khoom ua tau zoo ua ntej, thiab sib zog los muab txhua tus neeg siv khoom nrog high {4} Cov kev pabcuam siab kom tau raws li lawv cov kev xav tau.
Pib los ntawm kev xaiv ceevfaj ntawm cov khoom siv raw, txhua kauj ruam ntawm Xi'an Sonwu cov txheej txheem yog nruj me ntsis tswj. Xi'an Sonwu ua ntej high- cov khoom lag luam zoo, thiab nws txoj kev xaiv, xws li kev kuaj tsim khoom, thiab cov kws tshaj lij ntawm nws cov neeg ua haujlwm. Los ntawm kev tswj hwm kev tswj hwm txhua yam, xi'an sonwu muaj peev xwm txo cov nqi yam tsis muaj kev sib txawv, kom cov neeg yuav khoom ntawm tus nqi tshwj xeeb.
Xi'an Songwu yog txaus siab rau cov lus pom zoo nws tau txais los ntawm cov neeg siv khoom, uas muaj kev pom zoo qhov zoo ntawm cov khoom. Txhawm rau ntxiv cov khoom lag luam kev ntseeg siab, Xi'an Sonwu zoo siab los muab cov qauv rau koj sim.
|
Puab |
Qauv nyiaj |
Moq |
|
Hmoov |
10g |
10g |
Cov neeg siv khoom 'paub zoo

Yuav ua li cas oClacitinib malate ua haujlwm
Olacitinib Malaste HmoovYog ib feem peb {{- tiam egfr inhibitor tshwj xeeb tau tsim los rau hom phiaj T790M tsis kam. Tus yuam sij rau nws cov tshuab ntawm kev ua nyob rau hauv nws cov qauv molecular, uas ua zoo li EGFR Protectoring lub vev xaib T790M (nrog rau thawj qhov kev hloov pauv hloov). Piv rau kev tawm tsam eGR ua ntej, nws ua rau pom kev tiv thaiv mutant Egrr (suav nrog T790M +) tshaj tawm cov tsiaj qus {}} hom (ib txwm) egfr. Qhov kev xaiv siab no yog ib qho ntawm nws qhov tseem ceeb tshaj plaws. Los ntawm irreveribly khi rau mutant EGF (T790M +), nws blocking edghosphorthlation thiab kev ua kom muaj kev txhim kho ntawm erk / ras / raf / me3k / akt txoj kev. Yog tsis muaj cov cim no prolifative cov cim, qhov kev loj hlob thiab kev sib faib ntawm cov kabmob cell yog qhov loj me ntawm cov kabmob hlwb thiab tswj tus kab mob. Tub Ntxhais Muthat Protein
Piv txwv li Egfr yog cov protein rau ntawm cov xovtooj ntawm tes uas ua zoo li ib tus kav hlau txais xov, tau txais cov cim qhia cov cell kom loj hlob thiab faib cov. Hauv qee cov neeg mob uas tsis -} Tus kab mob hauv EGF yog thiab kev sib raug zoo "kom tsis tu ncua cov lus qhia rau qhov tsis muaj kev nkag siab ntawm cov cim. Ua ntej {{3 {}} thiab thib ob {4} {} { Ntawm cov no, T790M kev sib hloov nyiaj rau kev sib cais tseem ceeb. This mutation acts like a "lock" on the EGFR protein, preventing first- and second-generation drugs from binding to it, rendering them ineffective. OCLacitinib muaj cov ntshav zoo heev- kev nkag siab lub hlwb, cia nws nkag rau hauv lub hlwb thiab ua haujlwm rau hauv NSCLC. Qhov no yog lwm qhov txiaj ntsig zoo dua dhau los-} tiam siv yeeb tshuaj.

Dab tsi yog oclacitinib malate tau siv rau
1. Kev ceev ceev los ntawm khaus
Lub sijhawm pib nrawm ntawm oCLacitinib malate yog ib qho txiaj ntsig tseem ceeb. Raws li kev tshawb fawb, cov dev, cov dev tau tsawg dua plaub teev tom qab xa khoom ntawm qhov ncauj, thiab cov txiaj ntsig tau kawg rau nees nkaum- plaub teev. Ntxiv rau kev txhim kho tsiaj txhu kev nplij siab, cov tshuaj tiv thaiv ceev no tiv thaiv cov tawv nqaij theem nrab ntawm cov tawv nqaij theem nrab tau coj los ntawm cov khawb av nquag.
2. Ongic dermatitis kev tswj
Cov kab tom, kev noj haus tsis haum, thiab ib puag ncig cov hmoov av (xws li plua plav mites thiab pollen) yog cov ua rau atopic dermanic rau dev. Cov kev kho mob uas siv cov corticosteroids lossis tshuaj antihistamines, tab sis cov no muaj kev tsis zoo loj los sis tsis muaj txiaj ntsig zoo heev. OCLacitinib malate yog qhov kev kho mob loj rau aspic dermatitis ua xua los ntawm ntau txoj kev, loj hlob ntawm daim tawv nqaij erityema, khaus, thiab plaub hau poob.

3. Atopic Kev Kho Mob Dua
Ib qho zoo nkauj, tsis tu ncua, thiab rov tshwm sim tiv thaiv kab mob -} kev kho tawv nqaij yog atopic dermatitis. Cov dev nquag raug kev txom nyem los ntawm cov mob ob, tawv nqaij ua tuab, thiab mob khaus khaus khaus. OCLacitinib txhim kho cov dev 'zoo ntawm lub neej thiab cov nqi txo qis los ntawm theem kev tswj hwm kom sai thaum muaj mob siab thoob plaws thaum ntev.
4. BedCocorticoid kev vam khom
Txawm hais tias lawv lub peev xwm kom nrawm dua qhov mob ntshav, ntev - kev cuam tshuam ntawm cov ntshav qab zib, xws li lub cev muaj zog, lub siab tawv tawv. OCLacitinib Malaste tuaj yeem hloov pauv Glucocorticoids txog kev ua tau zoo thiab muaj tsawg dua kev phiv. Vim li no, cov kws kho tsiaj feem ntau yog clacitinib raws li thawj {{}} txoj kab kev kho.
Tsev tsim khoom
Xi'an Songwu Biotech CO, Ltd yog cov chaw tsim khoom uas yog rau kev sib koom ua ke ntawm kev tsim khoom, kev tsim khoom thiab muag khoom. Xi'an Sonwu muaj ntau tshaj kaum xyoo kev tsim khoom thiab kev tsim khoom, thiab nws muaj nws tus kheej cov khoom siv ntau lawm. Ib qho ntxiv, muaj cov cuab yeej ua haujlwm ywj pheej thiab kev tshaj lij kev sim rau peb cov khoom lag luam nrog cov khoom nruj thiab tsim cov khoom lag luam uas tau raws li cov neeg siv khoom xav tau.


Ntawv pov thawj

Ntim

Logistics

Dhau li ntawm kev lees paub cov khoom, lwm yam tseem ceeb tshaj plaws yog cov neeg siv khoom tuaj yeem tau txais cov khoom kom yooj yim. Yog li, Xi'an Sonwu cov khoom siv txhua hom ntawm cov kws qhia ntawv raws li cov kev xav tau sib txawv.

Cov FAQ
Indication Scope
Nws tau pom zoo rau kev siv nyob rau hauv cov dev, feem ntau los kho atopic thiab colergic dermatitis.
Vim tias tsis muaj kev nyab xeeb thiab kev tshawb nrhiav tau zoo, nws tsis pom zoo rau kev siv hauv tib neeg lossis miv.
Kev ceev faj thiab cov contraindications
Cov tub ntxhais hluas dev
Cov dev hnub nyoog qis dua 12 lub hlis tsis raug qhia, tshwj xeeb yog tias lawv tab tom loj tuaj.
Siv nrog cov dev me me uas tsawg dua 3 kg yog contraindicated.
Muaj me nyuam dev
Contraindicated rau cev xeeb tub thiab lactating poj niam dev.
Tsis pom zoo rau kev siv hauv txiv neej los yog poj niam deev dev vim tias tsis muaj kev tshawb fawb txog kev ua me nyuam.
Cov dev nrog cov mob hnyav
Yog tias tus dev muaj cov kab mob system, fungal, lossis kab mob cab, tus kab mob yuav tsum tau tswj hwm ua ntej siv.
Los ntawm Xi'an Sonwu tuam txhab ntau dua kaum -} xyoo kev,Olacitinib Malaste Hmoovyog tsuas yog muab rau hauv cov hmoov hmoov, lossis koj tuaj yeem siv cov xab npus thiab cream.
Yog li yog tias koj xav yuav PF 03394197 los yog txaus siab rau Xi'an Songwu, lossis muaj lwm cov lus nug txog cov khoom, tsuas yog hu rau Xi'an Sonwu.
Email:sales@sonwu.com
Cim npe nrov: OCLacitinib maleque hmoov, Tuam Tshoj, Tuam Tshoj chaw tsim khoom, chaw tsim khoom, lag luam, yuav, cov nqe, ntshiab, muab khoom, kev muag khoom














